Elucid

Elucid is a private Boston-based AI medical technology company focused on cardiovascular imaging analysis software. Its core commercial product, PlaqueIQ, is an FDA-cleared, non-invasive CT angiography image analysis solution that quantifies and characterizes arterial plaque morphology using algorithms trained and validated against ground-truth histology. The company is positioning its technology to help physicians assess atherosclerotic disease biology, improve risk stratification for heart attack and stroke, and support more personalized treatment decisions. Beyond plaque characterization, Elucid is also developing plaque-derived FFRCT and related imaging analytics capabilities. The company works with providers, researchers, and industry partners in cardiovascular diagnostics and precision medicine.